STAT - Reporting from the frontiers of health and medicine

Health

Politics

First Opinion

By Tina Rulli

Health An updated guide to the changing science of flu shots
Pharmalot Congressional Budget Office says Pelosi drug pricing bill could save $345 billion
Biotech ‘Gene therapy headwinds’ are blamed for biotech stock woes
First Opinion Wanted: better policies and incentives to revitalize R&D for new antimicrobial drugs
First Opinion Accounting for hope: using ‘mean survival gain’ to price new cancer drugs

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Most Americans back various ideas to lower drug costs, but some fear impeachment will get in the way
FDA bid to bolster generic competition and combat shortages isn’t working — yet
Pharmalittle: House progressives seek to change Pelosi bill; shortage of a critical cancer drug for kids

Health

Health

Health

By Brittany Flaherty

First Opinion

Special Report

First Opinion

By Dorothy Pomerantz

Health Ancestry launches consumer genetics tests for health, intensifying rivalry with 23andMe
Health An updated guide to the changing science of flu shots
First Opinion FDA is smashing the status quo for regulatory science
First Opinion Time in range: a new way for people with diabetes to monitor blood sugar
First Opinion Accounting for hope: using ‘mean survival gain’ to price new cancer drugs